Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss
Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are
Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting
Read time: 2 minutes. Of the more than 234,000 people who will be diagnosed with lung cancer in 2025, roughly 50% are ineligible for lung cancer screening according to current
Read time: 3 minutes. As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked
Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 4 minutes. Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal
Read time: 2 minutes. Integrative oncology combines conventional cancer treatments with complementary therapies to provide comprehensive care. It focuses on treating the whole
Read time: 2 minutes. Historically, approaches to treating lung cancer included surgery, radiation, and chemotherapy. The past decade ushered in a new era of treatments with
Read time: 2 minutes. What Is Integrative Oncology? Integrative oncology is the use of complementary therapies alongside conventional lung cancer treatments like chemotherapy
Read time: 3 minutes. Surgery is a treatment option for early-stage lung cancer that involves removing all or part of a lung to treat a cancerous tumor. It is primarily an option